Crystal Structure of HIV-1 Protease in Complex with Vx-478, a Potent and Orally Bioavailable Inhibitor of the Enzyme
Kim, E.E., Baker, C.T., Dwyer, M.D., Murcko, M.A., Rao, B.G., Tung, R.D., Navia, M.A.(1995) J Am Chem Soc 117: 1181-1182
Experimental Data Snapshot
wwPDB Validation 3D Report Full Report
(1995) J Am Chem Soc 117: 1181-1182
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
HIV-1 PROTEASE | 99 | Human immunodeficiency virus 1 | Mutation(s): 0 EC: 3.4.23 | ||
UniProt | |||||
Find proteins for P04587 (Human immunodeficiency virus type 1 group M subtype B (isolate BH5)) Explore P04587 Go to UniProtKB: P04587 | |||||
Entity Groups | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P04587 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
478 Query on 478 | C [auth B] | {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL-2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER C25 H35 N3 O6 S YMARZQAQMVYCKC-OEMFJLHTSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 63.4 | α = 90 |
b = 63.4 | β = 90 |
c = 83.8 | γ = 120 |
Software Name | Purpose |
---|---|
X-PLOR | model building |
X-PLOR | refinement |
X-PLOR | phasing |